Repligen Corp

RGEN Nasdaq SEC CIK 730272
Follow Repligen Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $209.3M +10.9% vs same quarter last year
Net income −$38.4M −357.7% vs same quarter last year
EPS, diluted −$0.68 −361.5% vs same quarter last year
Operating cash flow $43.1M −10.4% vs same quarter last year
Revenue by quarter
$167.5M
$169.2M
$182.4M
$188.8M
$197.9M
$194.3M
$204.1M
$209.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$250M$0$250M$500M$750M$1BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$738.3M$48.9M
FY24$634.4M−$25.5M
FY23$632.4M$35.6M
FY22$801.5M$186M
FY21$670.5M$128.3M
FY20$366.3M$59.9M
FY19$270.2M$21.4M
FY18$194M$16.6M
FY17$141.2M$28.4M
FY16$104.5M$11.7M
FY15$83.5M$9.3M
FY14$63.5M$8.2M
FY13$68.2M$16.1M
FY12$62.3M$14.2M
FY11$27.3M−$1.6M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−25%0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2552.3%7.5%6.6%
FY2443.3%−5.5%−4%
FY2344%7.5%5.6%
FY2256.9%28%23.2%
FY2158.3%24.9%19.1%
FY2057.2%19.1%16.4%
FY1955.9%13.4%7.9%
FY1855.4%13.4%8.6%
FY1752.5%9.9%20.1%
FY1654.9%15.3%11.2%
FY1557.8%16.5%11.2%
FY1455.9%16.8%12.9%
FY1367%33.6%23.6%
FY1259.9%17.8%22.7%
FY1179.6%−1.4%−5.9%
Free cash flowOperating cash flow minus capital expenditure
$0$50M$100M$150MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$93.9M
FY24$149.7M
FY23$77.7M
FY22$87.2M
FY21$51.9M
FY20$40.2M
FY19$48.7M
FY18$22.1M
FY17$12M
FY16$3.2M
FY15$12.4M
FY14$12.8M
FY13$21.3M
FY12$12.2M
FY11$2.7M
Returned to shareholdersDividends paid and shares bought back
$0$5M$10M$15MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$0
FY24$0
FY23$14.4M
FY22$0
FY21$0
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Repligen
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRepligenHealthcare median
FY256.6%−30.6%
FY24−4%−47%
FY235.6%−58%
FY2223.2%−80.4%
FY2119.1%−71.8%
FY2016.4%−62.2%
FY197.9%−46.2%
FY188.6%−49.6%
FY1720.1%−45.9%
FY1611.2%−36%
FY1511.2%−37.8%
FY1412.9%−35.5%
FY1323.6%−37.1%
FY1222.7%−29.1%
FY11−5.9%−27.9%